![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Ajinomoto Co., Inc. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Glutamic Acid, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1998-066 - Rev 01
This Chemical Type CEP, issued on September 29, 2006, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 750 associated with this CEP further emphasizes